LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,730,000 | +49.7% | 500,764 | +39.7% | 0.00% | +100.0% |
| Q4 2016 | $2,491,000 | -12.3% | 358,466 | +3.9% | 0.00% | 0.0% |
| Q3 2016 | $2,839,000 | +8.4% | 344,959 | +6.7% | 0.00% | 0.0% |
| Q2 2016 | $2,619,000 | +61.3% | 323,355 | +1.1% | 0.00% | 0.0% |
| Q1 2016 | $1,624,000 | -30.8% | 319,759 | +5.1% | 0.00% | 0.0% |
| Q4 2015 | $2,347,000 | +37.9% | 304,121 | +2.8% | 0.00% | 0.0% |
| Q3 2015 | $1,702,000 | -30.4% | 295,698 | +10.8% | 0.00% | 0.0% |
| Q2 2015 | $2,447,000 | – | 266,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,188,331 | $15,209,000 | 19.14% |
| ACUTA CAPITAL PARTNERS, LLC | 3,809,944 | $26,479,000 | 9.85% |
| Avoro Capital Advisors LLC | 4,520,643 | $31,418,000 | 6.35% |
| Broadfin Capital, LLC | 2,638,259 | $18,336,000 | 2.04% |
| Perceptive Advisors | 3,567,553 | $24,794,000 | 1.76% |
| Ghost Tree Capital, LLC | 975,000 | $6,776,000 | 1.63% |
| Opaleye Management Inc. | 300,000 | $2,085,000 | 1.23% |
| Rhenman & Partners Asset Management AB | 650,000 | $4,518,000 | 0.87% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $1,043,000 | 0.39% |
| QVT Financial LP | 1,498,809 | $10,349,000 | 0.31% |